Historique
Auteur B. D. L. MARSHALL
Documents disponibles écrits par cet auteur (11)
Ajouter le résultat à votre sélection Affiner la recherche
K. M. WAYE ; J. L. YEDINAK ; J. KOZIOL ; B. D. L. MARSHALL | 2018
Dans International Journal of Drug Policy (Vol.62, December 2018) Article : PériodiqueBackground: In 2015, the state of Rhode Island reported the fifth highest drug overdose mortality rate in the United States. In response to this crisis, Rhode Island created a statewide, publicly accessible drug surveillance and information syst[...]![Global patterns of opioid use and dependence: harms to populations, interventions, and future action [Drug use 1]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_82246.webp)
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : PériodiqueWe summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]
M. S. KRIEGER ; J. L. YEDINAK ; J. A. BUXTON ; M. LYSYSHYN ; E. BERNSTEIN ; J. D. RICH ; T. C. GREEN ; S. E. HADLAND ; B. D. L. MARSHALL | 2018
Dans Harm Reduction Journal (Vol.15, n°1, 2018) Article : PériodiqueBackground: Synthetic opioid overdose mortality among young adults has risen more than 300% in the USA since 2013, primarily due to the contamination of heroin and other drugs with illicitly manufactured fentanyl. Rapid test strips, which can be[...]
E. WOOD ; R. S. HOGG ; V. D. LIMA ; T. KERR ; B. YIP ; B. D. L. MARSHALL ; J. S. G. MONTANER | 2008
Dans Journal of the American Medical Association (Vol.300, n°5, August 6, 2008) Article : PériodiqueCONTEXT: Highly active antiretroviral therapy (HAART) is often withheld from injection drug users (IDUs) infected with the human immunodeficiency virus (HIV) based on the belief that their unstable lifestyles may predetermine a markedly inferior[...]
E. CHILDS ; K. B. BIELLO ; P. K. VALENTE ; P. SALHANEY ; D. L. BIANCARELLI ; J. OLSON ; J. J. EARLYWINE ; B. D. L. MARSHALL ; A. R. BAZZI | 2021
Dans International Journal of Drug Policy (Vol.90, April 2021) Article : PériodiqueBackground: Harm reduction services, which typically provide overdose education and prevention with distribution of naloxone and other supplies related to safer drug use, help reduce opioid-related overdose and infectious disease transmission. H[...]
B. NOSYK ; B. D. L. MARSHALL ; B. FISCHER ; J. S. G. MONTANER ; E. WOOD ; T. KERR | 2012
Dans Drug and Alcohol Dependence (Vol.126, n°1-2, November 2012) Article : PériodiqueBackground: The nonmedical use of prescribed opioids (POs) has increased across North America over the past decade. Our objective was to identify changes in the availability of POs and other illicit drugs among drug users in a Canadian setting. [...]
S. E. HADLAND ; B. D. L. MARSHALL ; T. KERR ; C. LAI ; J. S. MONTANER ; E. WOOD | 2012
Dans American Journal on Addictions (Vol.21, n°5, September-October 2012) Article : PériodiqueBackground: Current drug-control strategies in Canada focus funding and resources predominantly on drug law enforcement, often at the expense of preventive, treatment, and harm reduction efforts. This study aimed to examine the availability of t[...]
B. D. L. MARSHALL ; M. J. MILLOY ; E. WOOD ; J. S. G. MONTANER ; T. KERR | 2011
Dans Lancet (The) (Vol.377, n°9775, Apr 23, 2011) Article : PériodiqueBackground: Overdose from illicit drugs is a leading cause of premature mortality in North America. Internationally, more than 65 supervised injecting facilities (SIFs), where drug users can inject pre-obtained illicit drugs, have been opened as[...]
T. W. LEVENGOOD ; G. H. YOON ; M. J. DAVOUST ; S. N. OGDEN ; B. D. L. MARSHALL ; S. R. CAHILL ; A. R. BAZZI | 2021
Dans American Journal of Preventive Medicine (Vol.61, n°5, November 2021) Article : PériodiqueContext: Supervised injection facilities are harm reduction interventions that allow people who inject drugs to use previously obtained substances under the supervision of health professionals. Although currently considered illegal under U.S. fe[...]
B. D. L. MARSHALL ; E. WOOD | 2010
Dans Journal of Acquired Immune Deficiency Syndromes (Vol.55, Suppl.1, December 1, 2010) Article : PériodiqueComprehensive HIV prevention interventions are increasingly recognized as critical in the global effort to reduce HIV transmission among people who use injection drugs. Scientific evidence clearly shows that a variety of biomedical, behavioral, [...]
D. S. GAUR ; B. P. JACKA ; T. C. GREEN ; E. A. SAMUELS ; S. E. HADLAND ; M. S. KRIEGER ; J. L. YEDINAK ; B. D. L. MARSHALL | 2020
Dans International Journal of Drug Policy (Vol.85, November 2020) Article : PériodiquePurpose: Drug overdose mortality remains a public health concern in many countries globally. In the US, overdoses involving synthetic opioids are the primary contributor to overdose mortality. We aimed to assess trends in overdose death due to s[...]
